Dawn Ebersole
Family · Petoskey, MINPI 1841732617
Payments from drug & device makers
Across 165 payments — averaging $28.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Intercept Pharmaceuticals, Inc.$554
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$425
- Gilead$408
- Takeda Pharmaceuticals U.S.A., Inc.$401
- Sanofi$371
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,67499%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,049 |
| Intercept Pharmaceuticals, Inc. | 8 | $554 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $425 |
| Gilead | 4 | $408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $401 |
| Sanofi | 13 | $371 |
| Ipsen Biopharmaceuticals, Inc | 4 | $286 |
| Johnson & Johnson | 10 | $279 |
| Janssen Scientific Affairs, LLC | 2 | $186 |
| Ardelyx, Inc. | 1 | $124 |
| Organon | 6 | $116 |
| Aimmune Therapeutics, Inc. | 1 | $104 |
| Madrigal Pharmaceuticals | 1 | $92 |
| Nestle Healthcare Nutrition Inc. | 4 | $75 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Amgen | 2 | $48 |
| Pfizer | 2 | $44 |
| Merck | 2 | $34 |
| Boehringer Ingelheim | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,715 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 43 | $1,283,218 |
| Skyrizi On-BodyRisankizumab-Rzaa | 14 | $298,437 |
| RinvoqUpadacitinib | 40 | $259,844 |
| Humira(Cf) PenAdalimumab | 19 | $237,182 |
| LinzessLinaclotide | 173 | $117,911 |
| Entyvio PenVedolizumab | 16 | $115,351 |
| XeljanzTofacitinib Citrate | 14 | $77,482 |
| Mesalamine | 74 | $76,966 |
| CreonLipase/Protease/Amylase | 34 | $67,221 |
| XifaxanRifaximin | 17 | $44,071 |
| Lubiprostone | 87 | $21,212 |
| IbsrelaTenapanor Hcl | 12 | $20,437 |
| MotegrityPrucalopride Succinate | 27 | $19,282 |
| Ursodiol | 51 | $13,652 |
| Budesonide DrBudesonide | 105 | $13,460 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $279 | $1,283,21843 claims |
| AbbVieRinvoq, Linzess, Creon | $1,049 | $444,975247 claims |
| PfizerXeljanz | $44 | $77,48214 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $425 | $44,07117 claims |
| Ardelyx, Inc.Ibsrela | $124 | $20,43712 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $401 | $19,28227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Petoskey
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.